Results 231 to 240 of about 1,719,335 (360)
This study develops enucleated MSC‐derived microvesicles (Mito@euMVs) to deliver functional mitochondria for optimizing wound repair. By efficiently encapsulating mitochondria, Mito@euMVs rejuvenate hyperglycemia‐induced senescent fibroblasts and HUVECs. Using PVA microneedle patches, the therapeutic efficacy of Mito@euMVs is validated in diabetic rats
Zixuan Dong+3 more
wiley +1 more source
Coactosin‐like protein inhibits prostaglandin D₂ (PGD2) secretion by modulating alveolar macrophage polarization, thereby suppressing activation of the PGD2 receptor CRTH2 in Th2‐associated immune cells and alleviating allergic airway inflammation.
Li‐Long Pan+12 more
wiley +1 more source
A comment on "Association between oral microbiome diversity and chronic obstructive pulmonary disease in the US population". [PDF]
Luo M, Xin K, Luo T.
europepmc +1 more source
The Gompertz law‐based biological age metric (GOLD BioAge) introduces interpretable convenient and interpretable calculations to capture mortality, disease, and frailty risks. Its applications to proteomics and metabolomics (ProtAge and MetAge) demonstrate clinical potential to enhance aging evaluation and prevent age‐related diseases.
Meng Hao+14 more
wiley +1 more source
Nutritional Support of Chronic Obstructive Pulmonary Disease. [PDF]
Simon P+9 more
europepmc +1 more source
CARDIOGRAPHIC ASSESSMENT OF PULMONARY VASCULAR DISEASE IN VENTRICULAR SEPTAL DEFECT [PDF]
A.S. Hollman+2 more
openalex +1 more source
Y332D, a bispecific antibody that simultaneously blockades VEGF and TGF‐β, counteracted negative RT effects that are attributed to the upregulation of TGF‐β and VEGF, as well as further enhanced the immunostimulatory effects of RT, thereby reprograming the TME from immune “cold” to inflamed state and forming an effective in‐situ vaccine that eradicate ...
Lijuan Lyu+13 more
wiley +1 more source
Multi-omics characterization of early chronic obstructive pulmonary disease. [PDF]
Li B+19 more
europepmc +1 more source